Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Patrizia Piccioli, Cristiana Fava, Claudio Leo, Roberta Carosio, Stefania Laurent, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Angelo Battaglia, Paolo A. Ascierto, Mariaelena Capone, Ester Simeone, Federica De Galitiis, Elena Pagani, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Mario Mandalà, Barbara Merelli, Pietro Quaglino, Paolo Fava, Massimo Guidoboni, Massimo Romani, Francesco Spagnolo, Maria Pia Pistillo

Open source

DOI
10.3389/fimmu.2017.00386
Published
2017-04-12
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2017.00386,
  title = {Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study},
  author = {Paola Queirolo and Beatrice Dozin and Anna Morabito and Barbara Banelli and Patrizia Piccioli and Cristiana Fava and Claudio Leo and Roberta Carosio and Stefania Laurent and Vincenzo Fontana and Pier Francesco Ferrucci and Chiara Martinoli and Emilia Cocorocchio and Angelo Battaglia and Paolo A. Ascierto and Mariaelena Capone and Ester Simeone and Federica De Galitiis and Elena Pagani and Gian Carlo Antonini Cappellini and Paolo Marchetti and Michele Guida and Stefania Tommasi and Mario Mandalà and Barbara Merelli and Pietro Quaglino and Paolo Fava and Massimo Guidoboni and Massimo Romani and Francesco Spagnolo and Maria Pia Pistillo},
  year = {2017},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2017.00386},
  url = {https://doi.org/10.3389/fimmu.2017.00386}
}

RIS

TY  - JOUR
TI  - Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
AU  - Paola Queirolo
AU  - Beatrice Dozin
AU  - Anna Morabito
AU  - Barbara Banelli
AU  - Patrizia Piccioli
AU  - Cristiana Fava
AU  - Claudio Leo
AU  - Roberta Carosio
AU  - Stefania Laurent
AU  - Vincenzo Fontana
AU  - Pier Francesco Ferrucci
AU  - Chiara Martinoli
AU  - Emilia Cocorocchio
AU  - Angelo Battaglia
AU  - Paolo A. Ascierto
AU  - Mariaelena Capone
AU  - Ester Simeone
AU  - Federica De Galitiis
AU  - Elena Pagani
AU  - Gian Carlo Antonini Cappellini
AU  - Paolo Marchetti
AU  - Michele Guida
AU  - Stefania Tommasi
AU  - Mario Mandalà
AU  - Barbara Merelli
AU  - Pietro Quaglino
AU  - Paolo Fava
AU  - Massimo Guidoboni
AU  - Massimo Romani
AU  - Francesco Spagnolo
AU  - Maria Pia Pistillo
PY  - 2017
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2017.00386
UR  - https://doi.org/10.3389/fimmu.2017.00386
ER  - 

APA

Queirolo, P., Dozin, B., Morabito, A., Banelli, B., Piccioli, P., Fava, C., Leo, C., Carosio, R., Laurent, S., Fontana, V., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Battaglia, A., Ascierto, P. A., Capone, M., Simeone, E., Galitiis, F. D., Pagani, E., Cappellini, G. C. A., Marchetti, P., Guida, M., Tommasi, S., Mandalà, M., Merelli, B., Quaglino, P., Fava, P., Guidoboni, M., Romani, M., Spagnolo, F., & Pistillo, M. P. (2017). Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.00386

Source records